Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,202.00
-18.00 (-1.48%)
At close: Feb 6, 2026
Kohjin Bio Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 5,203 | 5,206 | 4,770 | 4,742 | 3,947 | 3,137 | |
Revenue Growth (YoY) | 9.08% | 9.14% | 0.59% | 20.14% | 25.81% | 37.86% |
Cost of Revenue | 2,885 | 2,841 | 2,889 | 2,288 | 1,907 | 1,625 |
Gross Profit | 2,318 | 2,365 | 1,881 | 2,454 | 2,040 | 1,512 |
Selling, General & Admin | 1,281 | 1,206 | 1,024 | 1,186 | 1,069 | - |
Research & Development | 168 | 168 | 240 | - | - | - |
Other Operating Expenses | - | - | - | - | - | 801.92 |
Operating Expenses | 1,449 | 1,374 | 1,284 | 1,186 | 1,069 | 801.92 |
Operating Income | 869 | 991 | 597 | 1,268 | 971 | 709.8 |
Interest Expense | -35 | -30 | -22 | -32 | -38 | -36.18 |
Interest & Investment Income | 4 | 2 | - | - | - | - |
Earnings From Equity Investments | 88 | 98 | 71 | 10 | -29 | - |
Currency Exchange Gain (Loss) | - | - | 6 | -5 | 5 | - |
Other Non Operating Income (Expenses) | -6 | 3 | -18 | 2 | 9 | 289.68 |
EBT Excluding Unusual Items | 920 | 1,064 | 634 | 1,243 | 918 | 963.3 |
Gain (Loss) on Sale of Assets | - | 1 | - | - | 1 | - |
Other Unusual Items | 11 | -51 | - | - | 3 | - |
Pretax Income | 921 | 1,014 | 634 | 1,243 | 922 | 963.3 |
Income Tax Expense | 202 | 220 | 250 | 414 | 335 | 266.41 |
Net Income to Company | - | 794 | 384 | 829 | 587 | - |
Net Income | 719 | 794 | 384 | 829 | 587 | 696.89 |
Net Income to Common | 719 | 794 | 384 | 829 | 587 | 696.89 |
Net Income Growth | 87.24% | 106.77% | -53.68% | 41.23% | -15.77% | - |
Shares Outstanding (Basic) | 5 | 5 | 4 | 4 | 3 | - |
Shares Outstanding (Diluted) | 5 | 5 | 4 | 4 | 3 | - |
Shares Change (YoY) | 22.72% | 21.11% | - | 22.96% | - | - |
EPS (Basic) | 140.67 | 157.41 | 92.20 | 199.04 | 173.30 | - |
EPS (Diluted) | 140.67 | 157.41 | 92.20 | 199.04 | 173.30 | - |
EPS Growth | 52.57% | 70.74% | -53.68% | 14.85% | - | - |
Free Cash Flow | -316 | 53 | 261 | - | - | - |
Free Cash Flow Per Share | -61.82 | 10.51 | 62.66 | - | - | - |
Dividend Per Share | 24.000 | 24.000 | 14.000 | 19.000 | - | - |
Dividend Growth | 71.43% | 71.43% | -26.32% | - | - | - |
Gross Margin | 44.55% | 45.43% | 39.43% | 51.75% | 51.69% | 48.19% |
Operating Margin | 16.70% | 19.04% | 12.52% | 26.74% | 24.60% | 22.63% |
Profit Margin | 13.82% | 15.25% | 8.05% | 17.48% | 14.87% | 22.21% |
Free Cash Flow Margin | -6.07% | 1.02% | 5.47% | - | - | - |
EBITDA | 1,247 | 1,351 | 896 | - | - | - |
EBITDA Margin | 23.97% | 25.95% | 18.78% | - | - | - |
D&A For EBITDA | 378 | 360 | 299 | - | - | - |
EBIT | 869 | 991 | 597 | 1,268 | 971 | 709.8 |
EBIT Margin | 16.70% | 19.04% | 12.52% | 26.74% | 24.60% | 22.63% |
Effective Tax Rate | 21.93% | 21.70% | 39.43% | 33.31% | 36.33% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.